Page last updated: 2024-09-04

ertapenem and Neisseria gonorrhoeae Infection

ertapenem has been researched along with Neisseria gonorrhoeae Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Boyd, A; de Korne-Elenbaas, J; de Laat, M; de Vries, HJC; Heijman, T; Jongen, VW; Schim van der Loeff, MF; van Dam, AP; Wind, CM1
Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T1
Barker, L; Beck, C; Cole, MJ; Cook, C; Eyre, DW; Fifer, H; Gardiner, D; Gobin, M; Horner, P; Irish, C; Mohammed, H; Nathan, B; Phin, N; Pitt, R; Sanderson, N; Saunders, J; Sedgwick, J; Street, T; Town, K; Turbitt, D1
Cole, MJ; Ison, CA; Quaye, N1
Golparian, D; Lahra, MM; Limnios, A; Ohnishi, M; Tapsall, JW; Unemo, M; Whiley, D1
Alexander, S; Fenton, K; James, D; Livermore, DM; Marsden, B; Rudd, E; Warner, M1

Trials

1 trial(s) available for ertapenem and Neisseria gonorrhoeae Infection

ArticleYear
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.
    The Lancet. Infectious diseases, 2022, Volume: 22, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ertapenem; Fosfomycin; Gentamicins; Gonorrhea; Humans; Neisseria gonorrhoeae; Treatment Outcome

2022

Other Studies

5 other study(ies) available for ertapenem and Neisseria gonorrhoeae Infection

ArticleYear
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae

2021
Detection in the United Kingdom of the
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019, Volume: 24, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Drug Resistance, Bacterial; Ertapenem; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Treatment Outcome; United Kingdom; Whole Genome Sequencing

2019
Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefixime; Ertapenem; Gonorrhea; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae

2014
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Bacterial; Ertapenem; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae

2012
Activity of ertapenem against Neisseria gonorrhoeae.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gonorrhea; Humans; Lactams; Microbial Sensitivity Tests; Neisseria gonorrhoeae

2004
chemdatabank.com